| Literature DB >> 32021368 |
Rehab M Samaka1, Mohammed A Basha2, Eman Mansour3.
Abstract
PURPOSE: To evaluate the role of autophagy related gene 7 (ATG7) in non-melanoma skin cancer. SUBJECTS AND METHODS: This retrospective and prospective case-control study was performed on 104 patients with non-melanoma skin cancer (NMSC) in addition to 20 apparently healthy subjects matched for age and sex as a control group. Multiple skin biopsies were taken for immunohistochemical evaluation of ATG7 expression.Entities:
Keywords: BCC; NMSC; SCC; autophagy; autophagy related gene 7
Year: 2020 PMID: 32021368 PMCID: PMC6980838 DOI: 10.2147/CCID.S222051
Source DB: PubMed Journal: Clin Cosmet Investig Dermatol ISSN: 1178-7015
Demographic and Clinical Data of the SCC and BCC
| Item | SCC (n=27), n (%) | BCC (n=77), n (%) |
|---|---|---|
| X±SD | 54.2±20.3 | 59.7±18.2 |
| Median | 54 | 60 |
| Range | 6–77 | 15–90 |
| Male | 15 (55.6) | 35 (45.5) |
| Female | 12 (44.4) | 42 (54.5) |
| Head and neck | 18 (66.7) | 65 (84.4) |
| Trunk | 6 (22.2) | 12 (15.6) |
| Extremities | 3 (11.1) | 0 (0) |
| Ulcer | 10 (37) | 43 (55.8) |
| Mass | 17 (63) | 34 (44.2) |
| Not assessed | 6 (22.2) | 29 (37.7) |
| Not involved | 19 (70.4) | 44 (57.1) |
| Involved | 2 (7.4) | 4 (5.2) |
| Mean±SD | 3.7 | 3.2 |
| Min–Max | 0.5–15 | 0.2–12 |
| Median | 2.5 (2–3.5) | 3 (1.9–4) |
| Present | 0 (0) | 0 (0) |
| Absent | 27 (100) | 77 (100) |
| Present | 0 (0) | 0 (0) |
| Absent | 27 (100) | 77 (100) |
Abbreviations: LVI, lymphovascular invasion; n, number; X, mean; SD, standard deviation.
Figure 1A case of SCC. (A) Moderate-to-strong nucleocytoplasmic expression of ATG7 both in tumor and the surrounding stoma. (B) High power view of previous case. (C) Mild-to-moderate nucleocytoplasmic immunohistochemical expression of ATG7 in sebaceous gland (ATG7 IHC ×200 for A and C and ×400 for B).
Figure 3Normal skin. (A) Epidermis showed mild to moderate cytoplasmic expression of ATG7. (B) Dermis showed mild nucleocytoplasmic expression of ATG7 in hair follicle and eccrine sweat glands (ATG7 IHC ×200 for A and B).
Comparison Between Studied Groups Regarding ATG7 Expressions
| Epithelium | BCC (n=77) | SCC (n=27) | Control (n=20) | Test | |
|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | |||
| Positive | 77 (100) | 27 (100) | 20 (100) | NA | — |
| Negative | 0 (0) | 0 (0.0) | 0 (0) | ||
| Cytoplasmic | 0 (0) | 0 (0) | 11 (55) | χ2=62.8 | <0.001 |
| Nucleocytoplasmic | 77 (100) | 27 (100) | 9 (45) | ||
| X±SD | 251.7±43.2 | 207.04±44.6 | 85±32.2 | K=61.8 | <0.001 |
| Median | 260 | 200 | 80 | ||
| Range | 140 – 300 | 120 – 300 | 30 – 130 | ||
| Low | 2 (2.6) | 2 (7.4) | 20 (100) | χ2=99.7 | <0.001 |
| High | 75 (97.4) | 25 (92.6) | 0 (0) | ||
| Positive | 77 (100) | 27 (100) | 20 (100) | NA | — |
| Negative | 0 (0) | 0 (0.0) | 0 (0) | ||
| Cytoplasmic | 0 (0) | 0 (0) | 10 (50) | χ2=56.6 | <0.001 |
| Nucleocytoplasmic | 77 (100) | 27 (100) | 10 (50) | ||
| X±SD | 234.3±55.6 | 169.4±54 | 49±27.7 | K=64.9 | <0.001 |
| Median | 250 | 160 | 45 | ||
| Range | 60–300 | 80–300 | 10–100 | ||
| Low | 6 (7.8) | 7 (25.9) | 20 (100) | χ2=69.1 | <0.001 |
| High | 71 (92.2) | 20 (74.1) | 0 (0) | ||
Abbreviations: X, mean; SD, standard deviation; K, Kruskal Wallis test; n, number; χ2, chi-square test; NA, not applicable.
Relation Between ATG7 H Score and Clinical Parameters of the Patients
| Items H Score | All Patients (n=104) Mean±SD | Test of Sig. | |
|---|---|---|---|
| Head and neck | 242.8±45.5 | Kruskal Wallis=4.5 | 0.11 |
| Trunk | 236.7±55.5 | ||
| Extremities | 183.3±15.3 | ||
| Ulcer | 243.6±46.7 | Mann Whitney=0.71 | 0.48 |
| Mass | 236.3±48.7 | ||
| Not assessed | 232.1±9.1 | Kruskal Walis=3.2 | 0.20 |
| Not involved | 246.8±42.4 | ||
| Involved | 213.3±51.6 | ||
| r=0.17 | |||
| Head and neck | 220.6±62.1 | Kruskal Wallis=3.4 | 0.19 |
| Trunk | 211.7±63.5 | ||
| Extremities | 165±13.2 | ||
| Ulcer | 220.8±54.3 | Mann Whitney=0.29 | 0.77 |
| Mass | 214.1±69.3 | ||
| Not assessed | 215.6±67.4 | Kruskal Wallis=0.96 | 0.62 |
| Not involved | 220.6±58.9 | ||
| Involved | 195±64.7 | ||
| r=0.12 | |||
Note: r, correlation coefficient.
Abbreviations: Sig., significant; SD, standard deviation.
Relationship Between ATG7 H Score (Epithelial and Stromal) and Clinical Parameters in SCC Patients
| Items | SCC Epithelial H Score Mean±SD | SCC Stromal H Score Mean±SD | Test of Sig. | |
|---|---|---|---|---|
| Head and neck | 212.8±38.2 | 172.2±52.1 | F=0.59* | P1=0.56 |
| Trunk | 236.7±55.5 | 163.3±76.1 | Kruskal Wallis=0.59** | P2=0.81 |
| Extremities | 183.3±15.3 | 165±13.2 | ||
| Ulcer | 215±36.3 | 178±44.4 | Mann Whitney=0.88* | P1=0.38 |
| Mass | 202.4±49.3 | 164.4±59.6 | t=0.62** | P2=0.53 |
| Not assessed | 185±21.7 | 150±28.4 | F=1.4* | P1=0.26 |
| Not involved | 216.3±49.1 | 177.9±60.5 | F=0.78** | P2=0.47 |
| Involved | 185±21.2 | 145±35.4 | ||
| r=−0.09 | P1=0.64 | |||
| I (11) | 206.4±13.7 | 180.9±64.7 | F=0.07* | P1=0.93 |
| II (12) | 210±49.5 | 50.8±37.8 | F=1.4** | P2=0.26 |
| III (4) | 200±35.6 | 193.8±58.5 | ||
Notes: F, one way Anova test; r, correlation coefficient; t, Student’s test; P1, relationship between epithelial H score and clinical parameters; P2, relationship between stromal H score and clinical parameters; *significance between SCC epithelial H score and clinical parameters; **significance between SCC stromal H score and clinical parameters.
Abbreviation: SD, standard deviation.
Relationship Between ATG7 H Score (Epithelial and Stromal) and Clinical Parameters in BCC Patients
| Items | BCC Epithelial H Score Mean±SD | BCC Stromal H Score Mean±SD | Test of Sig. | |
|---|---|---|---|---|
| Head and neck | 251.1±44.1 | 234±58.1 | Mann Whitney=0.007* | P1=0.99 (>0.05) |
| Trunk | 254.2±39.6 | 235.8±41 | Mann Whitney=0.33** | P2=0.74 (>0.05) |
| Ulcer | 250.2±46.7 | 230.7±51.9 | Mann Whitney=0.05* | P1=0.96 (>0.05) |
| Mass | 253.2±38.9 | 238.8±60.4 | Mann Whitney=1.04** | P2=0.29 (>0.05) |
| Not assessed | 242.1±53.7 | 228.9±65.4 | Kruskal Wallis=1.7* | P1=0.42 |
| Not involved | 260±31.5 | 239.1±48.2 | Kruskal Wallis=0.42** | P2=0.81 |
| Involved | 227.5±59.1 | 220±63.8 | ||
| r=0.25 | r=0.16 | P1=0.027 | ||
Notes: r, correlation coefficient; P1, relationship between BCC epithelial H score and clinical parameters; P2, relationship between BCC stromal H score and clinical parameters; *significance between BCC epithelial H score and clinical parameters; **significance between BCC stromal H score and clinical parameters.
Abbreviation: SD, standard deviation.
Figure 4(A) A significant positive correlation between H score (epithelial & stromal) of ATG7 in all patients (r=+0.48, P=0.00). (B) A significant positive correlation between H score (epithelial & stromal) of ATG7 in BCC patients (r=+0.29, P=0.009). (C) A significant positive correlation between H score (epithelial & stromal) of ATG7 in SCC patients (r=+0.61, P=0.00).
Notes: “r” describes the direction of correlation as either positive or negative, otherwise P-value shows a statistically significant correlation between studied groups. *Significant P-value; **highly significant P-value.